How does Pentostatin kill cancer cells?
Pentostatin blocks an enzyme called adenosine deaminase (ADA) that cancer cells need to survive. Without this enzyme, cancer cells can't make the proteins and DNA building blocks they need, so they die [7].
Pentostatin is a nucleoside metabolic inhibitor, meaning it stops cancer cells from breaking down and recycling nucleosides—the tiny building blocks of DNA and RNA. In clinical trials, patients with hairy cell leukemia achieved 90%+ complete remission rates using Pentostatin as a single agent, with some staying cancer-free for 10+ years [7].
Inside the cancer cell, Pentostatin acts like a lock on the ADA enzyme. When ADA is blocked, toxic metabolites pile up inside the cell, poisoning it from the inside out. This mechanism is especially deadly to lymphoid cancers (blood cancers) because those cells rely heavily on nucleoside metabolism to survive [7].
The trade-off is that Pentostatin also affects your healthy immune cells, which is why your blood counts drop and you become more prone to infections during treatment. Your oncology team will check your blood counts every 1–2 weeks and may pause treatment if your white blood cells or platelets fall too low [2][9].
Ask your oncology nurse: 'How often will you check my blood counts, and what numbers would cause you to pause my treatment?' This helps you understand the safety monitoring plan and know what to expect between infusions.